1. Home
  2. BDTX vs FITBO Comparison

BDTX vs FITBO Comparison

Compare BDTX & FITBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • FITBO
  • Stock Information
  • Founded
  • BDTX 2014
  • FITBO N/A
  • Country
  • BDTX United States
  • FITBO United States
  • Employees
  • BDTX N/A
  • FITBO 18616
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • FITBO Major Banks
  • Sector
  • BDTX Health Care
  • FITBO Finance
  • Exchange
  • BDTX Nasdaq
  • FITBO Nasdaq
  • Market Cap
  • BDTX 181.4M
  • FITBO N/A
  • IPO Year
  • BDTX 2020
  • FITBO N/A
  • Fundamental
  • Price
  • BDTX $3.35
  • FITBO $21.30
  • Analyst Decision
  • BDTX Strong Buy
  • FITBO
  • Analyst Count
  • BDTX 6
  • FITBO 0
  • Target Price
  • BDTX $12.50
  • FITBO N/A
  • AVG Volume (30 Days)
  • BDTX 822.6K
  • FITBO N/A
  • Earning Date
  • BDTX 11-04-2025
  • FITBO N/A
  • Dividend Yield
  • BDTX N/A
  • FITBO N/A
  • EPS Growth
  • BDTX N/A
  • FITBO N/A
  • EPS
  • BDTX 0.25
  • FITBO N/A
  • Revenue
  • BDTX $70,000,000.00
  • FITBO N/A
  • Revenue This Year
  • BDTX N/A
  • FITBO N/A
  • Revenue Next Year
  • BDTX N/A
  • FITBO N/A
  • P/E Ratio
  • BDTX $13.20
  • FITBO N/A
  • Revenue Growth
  • BDTX N/A
  • FITBO N/A
  • 52 Week Low
  • BDTX $1.20
  • FITBO N/A
  • 52 Week High
  • BDTX $5.69
  • FITBO N/A
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 65.14
  • FITBO 69.92
  • Support Level
  • BDTX $3.15
  • FITBO $21.00
  • Resistance Level
  • BDTX $3.43
  • FITBO $21.40
  • Average True Range (ATR)
  • BDTX 0.18
  • FITBO 0.25
  • MACD
  • BDTX 0.02
  • FITBO 0.07
  • Stochastic Oscillator
  • BDTX 89.19
  • FITBO 92.00

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About FITBO Fifth Third Bancorp Depositary Shares each representing a 1/1000th ownership interest in a share of Non-Cumulative Perpetual Preferred Stock Series K

Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $210 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.

Share on Social Networks: